KEVIN KOCH

CIK 1185829 · President and CEO · last filed 2025-08-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.26M

Companies

2

Total Filings

31

Lifetime Open-Market Net

-$555.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EWTX President and CEO 64,997 $34.83 $2.26M -$555.6K 11 2025-08-14
Viridian Therapeutics, Inc.\DE (MGEN) Delisted Director $0 4 2020-05-22

Recent Filings · Page 2 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-08-19 EWTX Grant (A) $0 EDGAR
2020-05-22 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Grant (A) $0 EDGAR
2019-06-21 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Grant (A) $0 EDGAR
2018-06-28 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Grant (A) $0 EDGAR
2017-06-30 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Grant (A) $0 EDGAR
2013-08-02 Tax (F) −10,323 -$62.7K
2013-07-25 Mixed +9,921 $8.5K
2013-04-01 Grant (A) $0
2012-10-05 Grant (A) +22,718 $0
2012-04-03 Grant (A) $0
Showing 1120 of 31
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.